Lybrate.com has a nexus of the most experienced Oncologists in India. You will find Oncologists with more than 29 years of experience on Lybrate.com. You can find Oncologists online in Mumbai and from across India. View the profile of medical specialists and their reviews from other patients to make an informed decision.
Book Clinic Appointment
Submit a review for Dr. Uday PawarYour feedback matters!
Diabitic since 2001 .Taking Gelvas 50-500 Amaryl 1M, Ecospirin v75, Tezloc H, Flodart plus for D.M,heart, Microalbumin in urine and prostate problems.
I have listened that some american scientists invented the cure for cancers it true? Do you know any such cure for cancer?
While massaging my body today I got something hard on the left on my breast. It's something like a lump, when I pressed it. I felt pain. Please tell me what is it? Is it something to worry about?
Elevated PSA I am a 75 years old. My PSA last year was 4.03 this year it has elevated to 5.83. This has me stressed and worried. My urologist has recommend I have a biopsy. I have been reading and go ogling about prostate cancer and biopsies. The more I read and learn, the more confused I get. I am 50- to get a.
My wife Is suffering from stomach cancer stage4 and now vomits only blood no intake of food or drink not even medicine only survives on saline weight reduced from 75 kg to 40 kg. Age 65 years advise what to do.
My age is 23. Height 6 ft. Weight 76 kg. My question is that after what size adrenal tumour start producing symptoms?
My wife is having some liquid squeezing out of her breast when I press her breast. But she is not pregnant. What is the reason for that. Whether it is a problem or a common feature. Pls explain. She is not yet conceived till date.
Hi I am suffering from lung cancer stage 4 I am not having enough resistance to have chemotherapy what should I do Im in stage 4 what will be my life.
New research on urinary and sexual outcomes could eventually help prostate cancer patients decide on their course of treatment.
“The ultimate goal is to develop a predictive tool that lets patients decide which treatment is right for them based on the symptoms they have beforehand, and their tolerance for any change – even temporary – in those symptoms,” said researcher Matthew Johnson, MD in a press release. Dr. Johnson is a resident physician in the Department of Radiation Oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania, USA.
Dr. Johnson and his colleagues presented their study findings in September at the American Society for Radiation Oncology’s 56th Annual Meeting.
Their data came from two study groups of men with prostate cancer who received one of four treatments: intensity modulated radiation therapy (IMRT), low dose rate brachytherapy (LDR), post-prostatectomy IMRT (PPRT), or radical prostatectomy (RP).
Using questionnaires, the researchers assessed the men’s symptoms at baseline and after treatment.
One group of 3,515 men completed the American Urological Association Symptom Score, designed to evaluate urinary symptoms. Over 14,500 surveys were completed. Lower scores on this tool indicate better urinary function. This group was followed for a median of 28 months.
For patients who received IMRT, follow-up scores were slightly lower than baseline. PPRT patients had similar results. LDR patients tended to see an initial score increase when compared to IMRT patients, but fell back to comparable levels after 34 months. Men who underwent RP had lower scores at baseline and after treatment.
The Sexual Health Inventory for Men (SHIM) questionnaire was used to evaluate sexual symptoms in a group of 857 men who completed more than 2,600 surveys. Higher SHIM scores are associated with better sexual function. The median follow-up time was 18 months.
The scores of men who were treated with LDR and PPRT were not much different from those treated with IMRT. However, men who had had RP had the largest score decreases between baseline and follow-up.
These results could help clinicians counsel patients with prostate cancer, the authors noted. In this way, patients could have a better idea of what to expect in terms of urinary and sexual symptoms.
American Society for Radiation Oncology (ASTRO)
Johnson, M.E., et al.
“A Comparison of Urinary and Sexual Function Patient Reported Outcomes (PROs) Among Treatment Modalities for Prostate Cancer (PCa)”
(Abstract presented at ASTRO’s 56th Annual Meeting. September 16, 2014. Presentation #180)
Fox Chase Cancer Center
“Fox Chase Study Helps Identify When and How Much Various Prostate Cancer Treatments will Impact Urinary and Sexual Functioning”
(News release. September 16, 2014)
- See more at: http://www.issm.info/news/sex-health-headlines/prostate-cancer-treatments-and-urinary-sexual-functioning#sthash.Tym9DcEt.dpuf
How to analyse ultra sound (USG Abdomen) test? What is meant by prostate of 21.1 ML with insignificant residual urine of 20.4 ML. Two freely moving calculi are seen in GB.- Cholelithiasis?
Hi Dr. I am taking novelon tablet. Is this tablet sideeffect of breast cancer. Breast cancer chances increase by taking this tablet somebody tell me about. Is this true. But my Dr. gave me this tablet 21 days course.
What are the symptoms of lungs cancer I am using cigarette more than 5 years so this time I felt some problems like chest pain and through problems so I need a suggestion and how to reduce this or how to solve.
While sexual problems are common among colorectal cancer patients, they are not necessarily caused by surgical treatment, Dutch researchers report. The patients may already have sexual issues before surgery.
Noting that there was not much information available on colorectal cancer patients? sexual function and quality of sexual life before surgery, the researchers aimed to describe these aspects for both patients and their partners. They also wanted to use standardized sexual health assessments and compare the scores of those patients and partners to mean norm scores.
To do this, they recruited 136 patients who had been diagnosed with colorectal cancer, but had not yet undergone surgical treatment. One hundred six of the patients? partners were also involved.
To measure sexual function and quality of life, the researchers used several questionnaires.
Male patients and male partners completed the International Index of Erectile Function (IIEF), which assesses erectile function, orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction.
All of the women were given the Female Sexual Function Index (FSFI), which is used to evaluate arousal, lubrication, orgasmic function, sexual desire, sexual pain, and intercourse satisfaction.
Participants with partners completed the Golombok-Rust Inventory of Sexual Satisfaction (GRISS), which addresses the quality of sexual life. They were also given the Maudsley Marital Questionnaire (MMQ), which examines relationship issues.
Finally, all participants completed an adapted version of the Self-Administered Comorbidity Questionnaire, which provides data on any comorbidities.
Mean norm scores were provided in the manuals of each questionnaire.
The researchers found that when compared to mean norm scores, both male and female colorectal patients had lower scores on the sexual functioning and quality of sexual life domains on the given assessments. Female patients had lower sexual functioning and lower quality of sexual life than male patients. The partners also had lower scores in these areas when compared to mean norm scores. Male partners had lower scores than male patients.
The lower scores could be explained by stress, as there were not many differences between the scores of colon cancer patients and those with rectal cancer. Past research has shown high levels of stress in cancer patients and a link between psychological issues (such as stress, anxiety, and depression) and sexual dysfunction.
In spite of the lower scores, however, the participants? scores on relationship functioning were comparable to the corresponding mean norm scores, suggesting that the sexual issues did not seem to damage relationships.
The findings could help healthcare providers consider the sexual needs of colorectal cancer patients. ?More information provision and/or psychosexual guidance may be needed preoperatively in order to give license to couples to discuss sexual problems and to search for adequate professional support during any point in treatment, especially as the majority of patients do not take the initiative to discuss the treatment options for possible sexual dysfunction,? the authors wrote.
What is the treatment for prostrate. Remedial steps to prevent prostrate. Food habits to be adopted. Medicine for prostrate.
Uterine cancer is also known as endometrial cancer. It is a cancer which begins in the lining of the uterus. The uterus is the part of a woman's body where the fetus develops. Uterine cancer is one of those rare cancers in India, which can be diagnosed in its early stages. This is because excessive vaginal bleeding occurs, thus making it a very serious and an apparent symptom. It is also one of the few forms of cancer which can be cured as removing the uterus is often more than enough to cure the patient of uterine cancer.
Here are the causes, diagnosis and treatment of uterine cancer:
The exact cause of uterine cancer is not yet known, however, there is a theory on what causes uterine cancer. Hormones in a woman's body have been thought to increase the chances of getting uterine cancer. This is because it has long been thought that having high levels of estrogen is the cause of uterine cancer. Increased estrogen thickens the endometrium and thus, increases the likelihood of uterine cancer.
There are several tests used to diagnose whether you have uterine cancer including:
1. Pelvic exam: This is an examination in which the vagina, bladder, rectum and uterus are scanned for lumps. If they are found, it might be due to uterine cancer.
2. Pap test: A pap test is a special test designed to scan for uterine cancer.
3. Transvaginal ultrasound: A transvaginal ultrasound uses high-intensity sound waves so that pictures of the uterus can be taken.
4. Biopsy: During a biopsy, the doctor will remove tissue from the endometrium and it will then be analyzed for cancerous growths.
1. Surgery: This is the most common treatment as it removes the entire uterus and prevents the spreading of the cancer.
2. Chemotherapy: Chemotherapy involves giving drugs which kill cancerous cells. They are given through either an intravenous line or even in pill form.
3. Hormone therapy: This is a therapy in which either progesterone levels are increased or estrogen levels are decreased.
4. Radiation therapy: In this treatment, high energy laser beams are used to destroy cancerous cells.